Profound Medical (PROF) Revenue & Revenue Breakdown
Profound Medical Revenue Highlights
Latest Revenue (Y)
$7.33M
Latest Revenue (Q)
$1.90M
Main Segment (Y)
Recurring - non-capital
Main Geography (Y)
USA
Profound Medical Revenue by Period
Profound Medical Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $7.33M | 9.73% |
| 2022-12-31 | $6.68M | -2.79% |
| 2021-12-31 | $6.87M | -5.90% |
| 2020-12-31 | $7.30M | 72.61% |
| 2019-12-31 | $4.23M | 121.48% |
| 2018-12-31 | $1.91M | -51.01% |
| 2017-12-31 | $3.90M | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | - |
Profound Medical generated $7.33M in revenue during NA 2023, up 9.73% compared to the previous quarter, and up 383.71% compared to the same period a year ago.
Profound Medical Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $1.90M | -7.90% |
| 2023-12-31 | $2.06M | 19.47% |
| 2023-09-30 | $1.73M | 7.87% |
| 2023-06-30 | $1.60M | -13.87% |
| 2023-03-31 | $1.86M | 47.97% |
| 2022-12-31 | $1.26M | -38.23% |
| 2022-09-30 | $2.04M | 0.49% |
| 2022-06-30 | $2.02M | 48.46% |
| 2022-03-31 | $1.36M | 36.67% |
| 2021-12-31 | $998.00K | -60.66% |
| 2021-09-30 | $2.54M | -3.43% |
| 2021-06-30 | $2.63M | 269.48% |
| 2021-03-31 | $711.00K | -75.05% |
| 2020-12-31 | $2.85M | 27.98% |
| 2020-09-30 | $2.23M | 114.00% |
| 2020-06-30 | $1.04M | -5.41% |
| 2020-03-31 | $1.10M | -49.25% |
| 2019-12-31 | $2.17M | 320.63% |
| 2019-09-30 | $515.35K | 17.84% |
| 2019-06-30 | $437.32K | -60.43% |
| 2019-03-31 | $1.11M | -9.34% |
| 2018-12-31 | $1.22M | 418.72% |
| 2018-09-30 | $235.03K | 44.89% |
| 2018-06-30 | $162.21K | -44.34% |
| 2018-03-31 | $291.41K | -80.18% |
| 2017-12-31 | $1.47M | 24.49% |
| 2017-09-30 | $1.18M | 60.51% |
| 2017-06-30 | $735.94K | 65.92% |
| 2017-03-31 | $443.56K | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-03-31 | - | - |
Profound Medical generated $1.90M in revenue during Q1 2024, up -7.90% compared to the previous quarter, and up 151.27% compared to the same period a year ago.
Profound Medical Revenue Breakdown
Profound Medical Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 22 | Dec 21 |
|---|---|---|
| Capital equipment | $2.00M | $3.15M |
| Recurring - non-capital | $4.68M | $3.29M |
Profound Medical's latest annual revenue breakdown by segment (product or service), as of Dec 22: Recurring - non-capital (70.00%), and Capital equipment (30.00%).
Profound Medical Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|
| Germany | $1.80M | $1.43M | - | - |
| USA | $3.40M | $2.09M | - | - |
| Canada | $1.49M | $1.72M | - | - |
| C | - | - | $4.76M | $3.00M |
| D | - | - | $1.47M | $1.89M |
Profound Medical's latest annual revenue breakdown by geography, as of Dec 22: USA (50.82%), Germany (26.88%), and Canada (22.30%).
Profound Medical Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ITGR | Integer | $1.60B | $753.01M |
| LIVN | LivaNova | $1.15B | $318.60M |
| NVRO | Nevro | $425.17M | $101.90M |
| AORT | Artivion | $354.00M | $98.02M |
| FNA | Paragon 28 | $216.39M | $61.02M |
| KIDS | OrthoPediatrics | $148.73M | $52.80M |
| SIBN | SI-BONE | $138.89M | $39.97M |
| SRDX | Surmodics | $132.58M | $30.34M |
| SGHT | Sight Sciences | $81.06M | $21.37M |
| LUNG | Pulmonx | $68.67M | $20.78M |
| IRMD | IRadimed | $65.56M | $17.93M |
| NPCE | NeuroPace | $65.42M | $18.12M |
| CVRX | CVRx | $39.30M | $11.81M |
| OSA | ProSomnus | $27.65M | $7.46M |
| PROF | Profound Medical | $7.33M | $1.90M |
| OFIX | Orthofix Medical | $100.00K | $198.62M |
PROF Revenue FAQ
What is Profound Medical’s yearly revenue?
Profound Medical's yearly revenue for 2023 was $7.33M, representing an increase of 9.73% compared to 2022. The company's yearly revenue for 2022 was $6.68M, representing a decrease of -2.79% compared to 2021. PROF's yearly revenue for 2021 was $6.87M, representing a decrease of -5.90% compared to 2020.
What is Profound Medical’s quarterly revenue?
Profound Medical's quarterly revenue for Q1 2024 was $1.9M, a -7.90% decrease from the previous quarter (Q4 2023), and a 2.23% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $2.06M, a 19.47% increase from the previous quarter (Q3 2023), and a 64.24% increase year-over-year (Q4 2022). PROF's quarterly revenue for Q3 2023 was $1.73M, a 7.87% increase from the previous quarter (Q2 2023), and a -15.09% decrease year-over-year (Q3 2022).
What is Profound Medical’s revenue growth rate?
Profound Medical's revenue growth rate for the last 3 years (2021-2023) was 6.66%, and for the last 5 years (2019-2023) was 73.25%.
What are Profound Medical’s revenue streams?
Profound Medical's revenue streams in c 22 are Capital equipment, and Recurring - non-capital. Capital equipment generated $2M in revenue, accounting 30.00% of the company's total revenue, down -36.38% year-over-year. Recurring - non-capital generated $4.68M in revenue, accounting 70.00% of the company's total revenue, up 42.03% year-over-year.
What is Profound Medical’s main source of revenue?
For the fiscal year ending Dec 22, the largest source of revenue of Profound Medical was Recurring - non-capital. This segment made a revenue of $4.68M, representing 70.00% of the company's total revenue.